|
Insider Trading: Enzon Pharmaceuticals Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enzon Pharmaceuticals Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Enzon Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Enzon Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is ENZN.
The reporting company's CIK number is 727510.
The total value of stock buying since 2005 is $4,348,982.
The total value of stock sales is $440,998.
The total value of stock exercises is $316,625.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Enzon Pharmaceuticals Inc (ENZN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Enzon Pharmaceuticals Inc (ENZN) in the past 24 months. See table 2 for insider transaction details.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Enzon Pharmaceuticals Inc (ENZN).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-11 | 110,000 | 378,826 | 0 | 0 | 47,250 | 0 |
| 2008-09 | 0 | 0 | 0 | 0 | 15,000 | 0 |
| 2008-07 | 0 | 0 | 0 | 0 | 33,192 | 0 |
| 2008-05 | 0 | 0 | 20,487 | 194,188 | 28,500 | 111,000 |
| 2007-08 | 65,000 | 469,875 | 0 | 0 | 0 | 0 |
| 2007-07 | 131,705 | 1,017,413 | 0 | 0 | 14,160 | 0 |
| 2007-05 | 1,000 | 8,189 | 0 | 0 | 0 | 0 |
| 2007-04 | 65,553 | 539,695 | 0 | 0 | 0 | 0 |
| 2007-03 | 111,552 | 917,626 | 0 | 0 | 0 | 0 |
| 2007-02 | 68,910 | 600,895 | 0 | 0 | 0 | 0 |
| 2007-01 | 0 | 0 | 0 | 0 | 40,000 | 117,500 |
| 2006-12 | 0 | 0 | 30,000 | 246,810 | 30,000 | 88,125 |
| 2006-07 | 0 | 0 | 0 | 0 | 7,530 | 0 |
| 2006-03 | 40,000 | 273,778 | 0 | 0 | 0 | 0 |
| 2005-10 | 12,000 | 85,185 | 0 | 0 | 0 | 0 |
| 2005-06 | 10,000 | 57,500 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Enzon Pharmaceuticals Inc (ENZN)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-23 | Davit Paul Stephen (Exec. Vice Pres. HR) | Option Exercise | 3,000 | .00 | 0 |
| 2008-11-23 | Del Campo Ralph (EVP - Technical Operations) | Option Exercise | 3,000 | .00 | 0 |
| 2008-11-23 | Horak Ivan D (EVP, R&D, Chief Scientific Officer) | Option Exercise | 2,250 | .00 | 0 |
| 2008-11-23 | Tooman Craig A (Exec VP Finance, CFO) | Option Exercise | 3,000 | .00 | 0 |
| 2008-11-23 | Buchalter Jeffrey H (Chairman, CEO & President) | Option Exercise | 36,000 | .00 | 0 |
| 2008-11-17 | Classon Rolf A (Director) | Purchase | 10,000 | 4.04 | 40,400 |
| 2008-11-14 | Renfro Phillip M (Director) | Purchase | 10,000 | 3.64 | 36,407 |
| 2008-11-14 | Ando Goran (Director) | Purchase | 15,000 | 3.77 | 56,514 |
| 2008-11-13 | Micati Victor P (Director) | Purchase | 15,000 | 3.28 | 49,270 |
| 2008-11-13 | Buchalter Jeffrey H (Chairman, CEO & President) | Purchase | 50,000 | 3.28 | 164,035 |
| 2008-11-13 | Salisbury Robert C (Director) | Purchase | 10,000 | 3.22 | 32,200 |
| 2008-09-02 | Horak Ivan D (EVP, R&D, Chief Scientific Ofc) | Option Exercise | 15,000 | .00 | 0 |
| 2008-07-03 | Renfro Phillip M (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2008-07-03 | Micati Victor P (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2008-07-03 | Ando Goran (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2008-07-03 | Classon Rolf A (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2008-07-03 | Lebuhn Robert (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2008-07-02 | Renfro Phillip M (Director) | Option Exercise | 3,172 | .00 | 0 |
| 2008-07-02 | Micati Victor P (Director) | Option Exercise | 3,172 | .00 | 0 |
| 2008-07-02 | Salisbury Robert C (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2008-07-02 | Ando Goran (Director) | Option Exercise | 3,172 | .00 | 0 |
| 2008-07-02 | Classon Rolf A (Director) | Option Exercise | 3,172 | .00 | 0 |
| 2008-07-02 | Lebuhn Robert (Director) | Option Exercise | 3,172 | .00 | 0 |
| 2008-07-01 | Renfro Phillip M (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2008-07-01 | Micati Victor P (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2008-07-01 | Salisbury Robert C (Director) | Option Exercise | 4,427 | .00 | 0 |
| 2008-07-01 | Ando Goran (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2008-07-01 | Classon Rolf A (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2008-07-01 | Lebuhn Robert (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2008-05-12 | Davit Paul Stephen (Exec. Vice Pres. HR) | Option Exercise | 4,500 | .00 | 0 |
| 2008-05-12 | Del Campo Ralph (EVP - Technical Operations) | Option Exercise | 4,500 | .00 | 0 |
| 2008-05-12 | Renfro Phillip M (Director) | Sale | 15,000 | 9.49 | 142,281 |
| 2008-05-12 | Renfro Phillip M (Director) | Option Exercise | 15,000 | 7.40 | 111,000 |
| 2008-05-12 | Tooman Craig A (Exec VP Finance, CFO) | Option Exercise | 4,500 | .00 | 0 |
| 2008-05-09 | Renfro Phillip M (Director) | Sale | 5,487 | 9.46 | 51,907 |
| 2007-08-20 | Buchalter Jeffrey H (Chairman, CEO & President) | Purchase | 5,000 | 7.46 | 37,275 |
| 2007-08-02 | Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) | Purchase | 60,000 | 7.21 | 432,600 |
| 2007-07-24 | Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) | Purchase | 55,000 | 7.71 | 424,050 |
| 2007-07-16 | Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) | Purchase | 22,192 | 7.75 | 171,988 |
| 2007-07-12 | Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) | Purchase | 500 | 7.71 | 3,855 |
| 2007-07-11 | Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner) | Purchase | 54,013 | 7.73 | 417,520 |
| 2007-07-03 | Renfro Phillip M (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2007-07-03 | Micati Victor P (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2007-07-03 | Salisbury Robert C (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2007-07-03 | Ando Goran (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2007-07-03 | Classon Rolf A (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2007-07-03 | Lebuhn Robert (Director) | Option Exercise | 1,105 | .00 | 0 |
| 2007-07-01 | Renfro Phillip M (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2007-07-01 | Micati Victor P (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2007-07-01 | Salisbury Robert C (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2007-07-01 | Ando Goran (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2007-07-01 | Classon Rolf A (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2007-07-01 | Lebuhn Robert (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2007-05-11 | Tooman Craig A (Exec VP Finance, CFO) | Purchase | 1,000 | 8.19 | 8,189 |
| 2007-04-11 | Swieca Henry (10% Owner) | Purchase | 10,000 | 8.25 | 82,516 |
| 2007-04-10 | Swieca Henry (10% Owner) | Purchase | 10,253 | 8.25 | 84,587 |
| 2007-04-09 | Swieca Henry (10% Owner) | Purchase | 45,300 | 8.22 | 372,592 |
| 2007-03-02 | Swieca Henry (10% Owner) | Purchase | 111,552 | 8.23 | 917,626 |
| 2007-02-15 | Highbridge Capital Corp (10% Owner) | Purchase | 68,910 | 8.72 | 600,895 |
| 2007-01-02 | Lebuhn Robert (Director) | Option Exercise | 40,000 | 2.94 | 117,500 |
| 2006-12-11 | Classon Rolf A (Director) | Sale | 30,000 | 8.23 | 246,810 |
| 2006-12-11 | Classon Rolf A (Director) | Option Exercise | 30,000 | 2.94 | 88,125 |
| 2006-07-01 | Renfro Phillip M (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2006-07-01 | Micati Victor P (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2006-07-01 | Salisbury Robert C (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2006-07-01 | Ando Goran (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2006-07-01 | Classon Rolf A (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2006-07-01 | Lebuhn Robert (Director) | Option Exercise | 1,255 | .00 | 0 |
| 2006-03-07 | Horak Ivan D (EVP-R&D & Chief Scien. Officer) | Purchase | 6,000 | 6.87 | 41,208 |
| 2006-03-07 | Tooman Craig A (Exec VP Finance, CFO) | Purchase | 1,000 | 6.87 | 6,868 |
| 2006-03-07 | Buchalter Jeffrey H (Chairman, CEO & President) | Purchase | 20,000 | 6.84 | 136,732 |
| 2005-10-07 | Davit Paul Stephen (Exec. Vice Pres. HR) | Purchase | 6,500 | 7.03 | 45,695 |
| 2005-10-04 | Horak Ivan D (Chief Scien. Officer) | Purchase | 5,500 | 7.18 | 39,490 |
| 2005-06-10 | Buchalter Jeffrey H (Chief Executive Officer) | Purchase | 10,000 | 5.75 | 57,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Enzon Pharmaceuticals Inc (symbol ENZN,
CIK number 727510) see
the Securities and Exchange Commission (SEC) website.
|
|
